Definium Therapeutics, Inc. (DFTX)
40.98
-2.84
(-6.48%)
USD |
NASDAQ |
Aug 28, 16:00
41.00
+0.02
(+0.05%)
Pre-Market: 20:00
Definium Therapeutics EV to Assets (Quarterly)
EV to Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EV to Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -- |
| March 31, 2026 | -- |
| December 31, 2025 | -- |
| September 30, 2025 | -- |
| June 30, 2025 | -- |
| March 31, 2025 | -- |
| December 31, 2024 | -- |
| September 30, 2024 | -- |
| June 30, 2024 | -- |
| March 31, 2024 | -- |
| December 31, 2023 | -- |
| September 30, 2023 | -- |
| June 30, 2023 | -- |
| March 31, 2023 | -- |
| December 31, 2022 | -- |
| September 30, 2022 | -- |
| June 30, 2022 | -- |
| March 31, 2022 | -- |
| December 31, 2021 | -- |
| Date | Value |
|---|---|
| September 30, 2021 | -- |
| June 30, 2021 | -- |
| March 31, 2021 | -- |
| December 31, 2020 | -- |
| September 30, 2020 | -- |
| June 30, 2020 | -- |
| March 31, 2020 | -- |
| August 31, 2019 | -- |
| May 31, 2019 | -- |
| February 28, 2019 | -- |
| November 30, 2018 | -- |
| August 31, 2018 | -- |
| May 31, 2018 | -- |
| February 28, 2018 | -- |
| November 30, 2017 | -- |
| August 31, 2017 | -- |
| May 31, 2017 | -- |
| February 28, 2017 | -- |
| November 30, 2016 | -- |
Enterprise Value Ratios (EV) Definition
Enterprise Value/Financial Metrics are often used by analysts to quickly look at a company's valuation multiples. All things being equal, the lower this ratio is, the better.
EV to Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median